PNC Financial Services Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-22
Closed -$2K 4235
2016
Q4
$2K Sell
22
-3
-12% -$338 ﹤0.01% 3868
2016
Q3
$4K Sell
25
-16
-39% -$1.59K ﹤0.01% 3725
2016
Q2
$4K Buy
41
+21
+105% +$2.6K ﹤0.01% 3960
2016
Q1
$3K Sell
20
-53
-73% -$10.7K ﹤0.01% 4088
2015
Q4
$24K Buy
73
+56
+329% +$18.2K ﹤0.01% 3213
2015
Q3
$6K Buy
17
+1
+6% +$439 ﹤0.01% 3907
2015
Q2
$6K Buy
16
+8
+100% +$3.4K ﹤0.01% 4025
2015
Q1
$4K Sell
8
-46
-85% -$17.8K ﹤0.01% 4105
2014
Q4
$19K Buy
54
+47
+671% +$14K ﹤0.01% 3171
2014
Q3
$1K Hold
7
﹤0.01% 3876
2014
Q2
$2K Hold
7
﹤0.01% 3565
2014
Q1
$2K Buy
+7
New +$2.14K ﹤0.01% 3534

Other funds holding LUMO

PNC Financial Services Group's LUMO Position: Q1 2017 in Review

PNC Financial Services Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2017, closing a stake of 22 shares — an estimated $2K sold.

PNC Financial Services Group first reported a position in LUMO in Q1 2014 and held it in 12 quarters. The position peaked at $24K in Q4 2015. 128 funds tracked by Wall St. Rank hold LUMO as of Q1 2017.

  • PNC Financial Services Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • PNC Financial Services Group sold 22 Lumos Pharma, Inc. Common Stock shares in Q1 2017, an estimated $2K.
  • PNC Financial Services Group first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2014 and held it in 12 quarters.
  • PNC Financial Services Group's Lumos Pharma, Inc. Common Stock position peaked at $24K in Q4 2015.
  • 128 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2017.

Based on PNC Financial Services Group's 13F filing for Q1 2017, filed 12 May 2017.